A study has evaluated de-identified data from wearable devices, discovering that this could improve real-time prediction of flu-like illnesses when compared with current surveillance methods.
Browsing: Influenza Virus
The first strain of flu we encounter during childhood could impact our immune responses to future infections, according to new research.
Two analyses supported by the Centers for Disease Control and Prevention’s US influenza data have demonstrated that immunization reduces the risk of hospitalization in children and death in adults
US FDA approves RECARBRIO™ for complicated UTIs and complicated intra-abdominal infections: July’s industry headlines
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
Research presented at ECCMID examining influenza transmission has discovered that a substantial proportion of patients and healthcare workers shed the flu virus before clinical symptoms appear.
The WHO has released a Global Influenza Strategy for 2019–2030 aiming to prevent seasonal flu, prepare for a pandemic situation and control the spread of zoonotic influenza.
Collaborative research efforts with scientists from Janssen, the Scripps Research Institute, the University of Hong Kong, the University of Pennsylvania and more has led to success in creating a promising novel long-lasting llama-derived antibody therapy for influenza.
Roche has announced the FDA approval of Xofluza™, the first and only single-dose oral medicine approved to treat flu.
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
A high-fiber diet can boost the immune response and increase survival in mice infected with influenza virus, according to new research.